Avricore Health Valuation

Is AVCR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AVCR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate AVCR's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate AVCR's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AVCR?

Key metric: As AVCR is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for AVCR. This is calculated by dividing AVCR's market cap by their current revenue.
What is AVCR's PS Ratio?
PS Ratio	1.4x
Sales	CA$4.48m
Market Cap	CA$6.06m

AVCR key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.2x
Enterprise Value/EBITDA	10.6x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does AVCR's PS Ratio compare to its peers?

The above table shows the PS ratio for AVCR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	5.7x
CRBK Carebook Technologies	0.4x	n/a	CA$5.1m
KOVO Kovo+ Holdings	0.4x	n/a	CA$6.0m
CDX.H Cloud DX	6.2x	n/a	CA$12.1m
TELE Telecure Technologies	15.9x	n/a	CA$7.6m
AVCR Avricore Health	1.4x	n/a	CA$6.1m

Price-To-Sales vs Peers: AVCR is good value based on its Price-To-Sales Ratio (1.4x) compared to the peer average (2.3x).

Price to Sales Ratio vs Industry

How does AVCR's PS Ratio compare vs other companies in the CA Healthcare Services Industry?

7 Companies	Price / Sales	Estimated Growth	Market Cap
THNK Think Research	0.3x	6.5%	US$17.84m
KOVO Kovo+ Holdings	0.4x	n/a	US$4.29m
CRBK Carebook Technologies	0.4x	n/a	US$3.68m
CBP Certive Solutions	1x	n/a	US$1.27m

7 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: AVCR is good value based on its Price-To-Sales Ratio (1.4x) compared to the North American Healthcare Services industry average (2.3x).

Price to Sales Ratio vs Fair Ratio

What is AVCR's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AVCR PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	1.4x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate AVCR's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

NeuPath Health

CA$9.6m

Provides chronic pain management services in Canada.

NPTH

CA$0.16

-5.9%

Hamilton Thorne

CA$344.7m

Develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets.

HTL

CA$2.24

79.2%

Medical Facilities

CA$362.7m

Through its subsidiaries, owns and operates specialty hospitals and ambulatory surgery center in the United States.

CA$15.87

83.9%